Where the Money Goes

You are here

Co-Funded Projects

Alex's Lemonade Stand Foundation is proud to partner with nearly 20 different childhood cancer charities to bring us closer to cures. Together, we are supporting the most cutting-edge research in the fight against childhood cancer. View projects supported in collaboration with our charity partners below!


Project Title Institution Co-Funder(s)
Effects of standardized, prospective Epstein-Barr virus (EBV) monitoring on the natural history and outcomes of post-transplant lymphoproliferative disorder and EBV-associated smooth muscle tumor in pediatric solid organ transplantation patients Children’s Hospital of Philadelphia Northwestern Mutual Foundation
Identification of phenotypic effects of genomic changes in retinoblastoma tumors using an aqueous humor liquid biopsy Children’s Hospital Los Angeles Northwestern Mutual Foundation
Incidence and grades of adverse events during treatment for pediatric acute lymphoblastic leukemia Emory University Northwestern Mutual Foundation
IL7 signaling enhanced CAR T cells to treat pediatric solid tumors Baylor College of Medicine Northwestern Mutual Foundation
Targeting the Checkpoint Receptor TIGIT via CRISPR/Cas9 Genome Editing to Enhance NK Cell Anti-Tumor Activity Research Institute at Nationwide Children's Hospital Northwestern Mutual Foundation
Synthetic Gene Expression Regulatory Switches (SynGERS) for Improved CAR T Cell Function in Pediatric Solid Tumors Baylor College of Medicine Northwestern Mutual Foundation
Arginine Depletion with DFMO in High-Risk Neuroblastoma Children’s Hospital of Philadelphia Northwestern Mutual Foundation
A Novel Adjunctive LAT-Activating CART (ALA-CART) Cell Platform for the Treatment of Acute Leukemia University of Colorado Denver_ Anschutz Medical Campus Northwestern Mutual Foundation
Investigating the Role of the MYCN Oncogene in Regulating Chemokine Expression in Neuroblastoma Children’s Hospital of Philadelphia Northwestern Mutual Foundation
Structural rearrangement signatures as novel biomarkers for homologous recombination deficiency in cancer Dana-Farber Cancer Institute Northwestern Mutual Foundation

Pages